PNC Financial Services Group
DYN icon

PNC Financial Services Group’s Dyne Therapeutics DYN Stock Holding History

PNC Financial Services Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Sell
537
-384
-42% -$7.14K ﹤0.01% 4013
2026
Q1 		$16.7K Buy
921
+503
+120% +$8.67K ﹤0.01% 3767
2025
Q4 		$8.18K Sell
418
-42
-9% -$795 ﹤0.01% 4041
2025
Q3 		$5.82K Buy
460
+250
+119% +$2.85K ﹤0.01% 4143
2025
Q2 		$2K Buy
210
+185
+740% +$2.04K ﹤0.01% 4409
2025
Q1 		$262 Buy
25
+4
+19% +$57 ﹤0.01% 4743
2024
Q4 		$495 Sell
21
-119
-85% -$3.52K ﹤0.01% 4532
2024
Q3 		$5.03K Buy
140
+111
+383% +$4.42K ﹤0.01% 4036
2024
Q2 		$1.02K Buy
29
+19
+190% +$552 ﹤0.01% 4418
2024
Q1 		$284 Buy
+10
New +$226 ﹤0.01% 4565

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PNC Financial Services Group's DYN Position: Q2 2026 in Review

PNC Financial Services Group reduced its Dyne Therapeutics (DYN) stake by 42% in Q2 2026, selling an estimated $7.14K and leaving 537 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4013.

PNC Financial Services Group first reported a position in DYN in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.7K in Q1 2026. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • PNC Financial Services Group held 537 shares of Dyne Therapeutics worth $11.9K as of Q2 2026.
  • PNC Financial Services Group sold 384 Dyne Therapeutics shares in Q2 2026, an estimated $7.14K.
  • Dyne Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4013 holding.
  • PNC Financial Services Group first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • PNC Financial Services Group's Dyne Therapeutics position peaked at $16.7K in Q1 2026.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.